Domain I: the hidden face of antiphospholipid syndrome

被引：8

作者：

Pericleous, C. ^{[1
]}

Rahman, A. ^{[1
]}

机构：

[1] UCL, Div Med, Ctr Rheumatol Res, London WC1E 6JF, England

来源：

LUPUS | 2014年 / 23卷 / 12期

关键词：

Anti-domain I antibodies; thrombosis; pregnancy morbidity; 13TH INTERNATIONAL-CONGRESS; APL TESTS REPORT; BETA(2)-GLYCOPROTEIN I; PRECONFERENCE WORKSHOP; ANTICOAGULANT ACTIVITY; IGG ANTIBODIES; GLYCOPROTEIN-I; TASK-FORCE; AUTOANTIBODIES; RECOGNIZE;

D O I：

10.1177/0961203314540354

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

IgG antiphospholipid antibodies (aPL) against (2)-glycoprotein I ((2)GPI) can target any of its five domains; however, aPL against the N-terminal domain (anti-DI, aDI) are considered the most clinically relevant in the antiphospholipid syndrome (APS). Circulating levels of aDI are elevated in patients with APS compared with disease and healthy controls, and crucially aDI are prothrombotic in invivo and invitro models. In addition, human recombinant DI has been shown to abrogate aPL-induced thrombosis invivo. Therefore, although the potential of utilizing DI for management of APS is not yet fully defined, there is promise that DI could prove valuable both as a diagnostic and therapeutic tool.

引用

页码：1320 / 1323

页数：4

共 28 条

[1] β2-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome [J].

Agar, Cetin ;

van Os, Gwendolyn M. A. ;

Morgelin, Matthias ;

Sprenger, Richard R. ;

Marquart, J. Arnoud ;

Urbanus, Rolf T. ;

Derksen, Ronald H. W. M. ;

Meijers, Joost C. M. ;

de Groot, Philip G. .

BLOOD, 2010, 116 (08) :1336-1343

[2] A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome [J].

Agostinis, Chiara ;

Durigutto, Paolo ;

Sblattero, Daniele ;

Borghi, Maria O. ;

Grossi, Claudia ;

Guida, Filomena ;

Bulla, Roberta ;

Macor, Paolo ;

Pregnolato, Francesca ;

Meroni, Pier Luigi ;

Tedesco, Francesco .

BLOOD, 2014, 123 (22) :3478-3487

[3] Utility of Antiphosphatidylserine/Prothrombin and IgA Antiphospholipid Assays in Systemic Lupus Erythematosus [J].

Akhter, Ehtisham ;

Shums, Zakera ;

Norman, Gary L. ;

Binder, Walter ;

Fang, Hong ;

Petri, Michelle .

JOURNAL OF RHEUMATOLOGY, 2013, 40 (03) :282-286

[4] Anti-β2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile? [J].

Andreoli, Laura ;

Nalli, Cecilia ;

Motta, Mario ;

Norman, Gary L. ;

Shums, Zakera ;

Encabo, Susan ;

Binder, Walter L. ;

Nuzzo, Monica ;

Frassi, Micol ;

Lojacono, Andrea ;

Avcin, Tadej ;

Meroni, Pier-Luigi ;

Tincani, Angela .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (02) :380-383

[5] Antibodies to Domain I of β2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS) [J].

Banzato, A. ;

Pozzi, N. ;

Frasson, R. ;

De Filippis, V. ;

Ruffatti, A. ;

Bison, E. ;

Padayattil, S. J. ;

Denas, G. ;

Pengo, V. .

THROMBOSIS RESEARCH, 2011, 128 (06) :583-586

[6] 'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010 [J].

Bertolaccini, M. L. ;

Amengual, O. ;

Atsumi, T. ;

Binder, W. L. ;

de laat, B. ;

Forastiero, R. ;

Kutteh, W. H. ;

Lambert, M. ;

Matsubayashi, H. ;

Murthy, V. ;

Petri, M. ;

Rand, J. H. ;

Sanmarco, M. ;

Tebo, A. E. ;

Pierangeli, S. S. .

LUPUS, 2011, 20 (02) :191-205

[7] 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends [J].

Bertolaccini, Maria Laura ;

Amengual, Olga ;

Andreoli, Laura ;

Atsumi, Tatsuya ;

Chighizola, Cecilia B. ;

Forastiero, Ricardo ;

De Groot, Philip ;

Lakos, Gabriella ;

Lambert, Marc ;

Meroni, Pierluigi ;

Ortel, Thomas L. ;

Petri, Michelle ;

Rahman, Anisur ;

Roubey, Robert ;

Sciascia, Savino ;

Snyder, Melissa ;

Tebo, Anne E. ;

Tincani, Angela ;

Willis, Rohan .

AUTOIMMUNITY REVIEWS, 2014, 13 (09) :917-930

[8] Autoantibodies specific to a peptide of β2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes [J].

Colasanti, Tania ;

Alessandri, Cristiano ;

Capozzi, Antonella ;

Sorice, Maurizio ;

Delunardo, Federica ;

Longo, Agostina ;

Pierdominici, Marina ;

Conti, Fabrizio ;

Truglia, Simona ;

Siracusano, Alessandra ;

Valesini, Guido ;

Ortona, Elena ;

Margutti, Paola .

BLOOD, 2012, 120 (16) :3360-3370

[9] Pathogenic anti-β2-glycoprotein I antibodies recognize domain I of β2-glycoprotein I only after a conformational change [J].

de Laat, B ;

Derksen, RHWM ;

van Lummel, M ;

Pennings, MTT ;

de Groot, PG .

BLOOD, 2006, 107 (05) :1916-1924

[10] IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis [J].

de Laat, B ;

Derksen, RHWM ;

Urbanus, RT ;

de Groot, PG .

BLOOD, 2005, 105 (04) :1540-1545

← 1 2 3 →